Clinical Trials Logo

Epilepsy, Idiopathic Generalized clinical trials

View clinical trials related to Epilepsy, Idiopathic Generalized.

Filter by:
  • None
  • Page 1

NCT ID: NCT06388174 Recruiting - Epilepsy Clinical Trials

Idiopathic Generalized Epilepsy Syndromes

Start date: January 1, 2023
Phase:
Study type: Observational

The idiopathic generalized epilepsies (IGEs) have historically included the syndromes childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and epilepsy with generalized tonic-clonic seizures alone (GTCA). Recognition of the IGEs is important for clinical care, as it informs diagnosis, prevents unnecessary investigation, allows optimal selection of anti-seizure medications (ASMs), and provides prognostic guidance. According to the new ILAE definition in 2022, the study aims to describe the clinical features, electroencephalographic, imaging findings and long-term prognosis.

NCT ID: NCT03940326 Completed - Clinical trials for Epilepsy, Idiopathic Generalized

Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures

Start date: April 1, 2018
Phase: Phase 4
Study type: Interventional

This study is an open-label, active-controlled,non-inferiority trial comparing efficacy and safety of levetiracetam versus valproate in idiopathic generalized tonic-clonic epilepsy.